Skip to content

Phibro Animal Health

US · PAHC #2966 by market cap Listed 1970
33.29 -0.79 -2.32%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 33.91 -0.50%
After-hours 33.29 0.00%
39.9228.3133.292026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on PAHC?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -11.2% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has fallen to 2.5% of float.
  • Analyst tilt is Hold.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2849 U.S. stocks StockVane covers.

Last computed: 2026-11-21 14:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall A

The radar needs all six factors. Available grades are shown below.

Valuation A

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 13.3x Better than 64%
Forward P/E 11.1x Better than 74%
Price / Sales 0.9x Better than 79%
P/E vs own 5-yr range 20th pctl Better than 85%
Growth A

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 15.8% Better than 77%
Net income CAGR (3Y) 45.2% Better than 87%
Free cash flow CAGR (3Y) 34.7% Better than 77%
Profitability B

How much profit the business keeps from each dollar of sales and capital.

Gross margin 33.8% Better than 39%
Operating margin 12.8% Better than 59%
Net margin 6.6% Better than 48%
Return on equity 29.7% Better than 87%
Return on invested capital 11.7% Better than 74%
Momentum C+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -8.1% Better than 55%
6-month return 0.8% Better than 57%
12-month return (ex latest month) -3.2% Better than 30%
Distance below 52-week high 44.2% Better than 24%
Financial Health C-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.0x Better than 72%
Debt to assets 52.5% Better than 13%
Interest coverage 4.1x Better than 52%
Free cash flow / net income 9.9% Better than 3%
Analyst View N/A

What the Street thinks: share of Buy ratings and upside to the average target.

Not enough data to grade this factor.

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -7.45%
1M -14.20%
3M -5.08%
6M -0.81%
YTD -10.03%
1Y -17.41%
3Y +239.03%
5Y +73.05%

Key statistics

Price & volume

Prev close
34.08
Open
34.01
Day range
33.27 - 34.54
Avg price
33.51
Volume
155.54K
Turnover
5.21M
Amplitude
3.74%
52-week range
28.04 - 59.64

Valuation

P/E
13.70
P/E (TTM)
13.32
P/B
3.24
EPS
2.43
Net profit
98.66M
Net assets
417.67M

Share structure

Market cap
1.35B
Float cap
696.10M
Shares out
40.60M
Float shares
20.91M

Dividend & listing

Dividend (TTM)
0.48
Listing date
1970-01-01
52-week range 17% of range
28.04 59.64

44.2% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+239.97K net over the window

Short interest

Shares short
1.02M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Phibro Animal Health (PAHC)?

Phibro Animal Health last traded at 33.29. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Phibro Animal Health's market cap?

About 1.35B.

What is the P/E ratio of Phibro Animal Health?

The trailing twelve-month P/E is 13.32, below its own 5-year average of 39.11 — toward the bottom of its historical range (20.49% percentile). See the Valuation tab for the full history.

Does Phibro Animal Health pay a dividend?

Yes. The trailing dividend yield is 1.44%. Per-share dividends have risen or held for 7 straight years through 2025. See the Dividends tab for the full payment history.

Is Phibro Animal Health a buy according to analysts?

The consensus of 2 analysts is a Hold rating, with an average 12-month price target of 45.00, which implies 35.2% upside from the current price. This is not investment advice.

What is Phibro Animal Health's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Phibro Animal Health a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Phibro Animal Health discussion 0 comments

Add a comment